FDA’s authorisation of onvalescent plasma in COVID-19 treatment sparks debates
The US FDA on Sunday issued an emergency use authorization for investigational convalescent plasma in treating COVID-19 hospitalized patients. The announcement, however, raises concerns among medical experts.
14:38 | 24/08/2020
Prev Next
